Picture of Agios Pharmaceuticals logo

AGIO — Agios Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Agios scraps blood disorder drug program after study miss

Agios scraps blood disorder drug program after study miss

- Agios Pharmaceuticals AGIO.O said on Friday it will stop developing its experimental drug for a form of blood cancer after a mid-stage trial failed to show enough benefit.



(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Sahal Muhammed)

((Padmanabhan.Ananthan@thomsonreuters.com;))

Recent news on Agios Pharmaceuticals

See all news